GR1008168B - Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου - Google Patents

Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου

Info

Publication number
GR1008168B
GR1008168B GR20130100156A GR20130100156A GR1008168B GR 1008168 B GR1008168 B GR 1008168B GR 20130100156 A GR20130100156 A GR 20130100156A GR 20130100156 A GR20130100156 A GR 20130100156A GR 1008168 B GR1008168 B GR 1008168B
Authority
GR
Greece
Prior art keywords
preparation
antibacterial agent
parenteral formulation
fluoroquinolone antibacterial
formulation
Prior art date
Application number
GR20130100156A
Other languages
English (en)
Inventor
Ευαγγελος Ανδρεα Καραβας
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Αθηνα Γεωργιου Ηλιοπουλου
Βασιλικη Χρηστου Σαμαρα
Μορφης Νικολαου Αμπατζης
Γεωργιος Θεμιστοκλη Γκοτζαμανης
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20130100156A priority Critical patent/GR1008168B/el
Priority to PCT/EP2014/000668 priority patent/WO2014139677A1/en
Priority to EP14722987.6A priority patent/EP2976063A1/en
Publication of GR1008168B publication Critical patent/GR1008168B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Η παρούσα εφεύρεση αφορά υδατικό φαρμακευτικό σκεύασμα Μοξιφλοξασίνης ή κάποιου φαρμακευτικά αποδεκτού άλατος αυτής και προπυλενικής γλυκόλης για χρήση για την αντιμετώπιση λοιμώξεων των ανθρώπων ή ζώων. Η παρούσα εφεύρεση παρέχει επίσης μέθοδο για την παρασκευή του παραπάνω σκευάσματος.
GR20130100156A 2013-03-14 2013-03-14 Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου GR1008168B (el)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GR20130100156A GR1008168B (el) 2013-03-14 2013-03-14 Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
PCT/EP2014/000668 WO2014139677A1 (en) 2013-03-14 2014-03-13 Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof
EP14722987.6A EP2976063A1 (en) 2013-03-14 2014-03-13 Parenteral formulation of fluoroquinolone antibacterial agent and method for preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100156A GR1008168B (el) 2013-03-14 2013-03-14 Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου

Publications (1)

Publication Number Publication Date
GR1008168B true GR1008168B (el) 2014-04-08

Family

ID=50687438

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100156A GR1008168B (el) 2013-03-14 2013-03-14 Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου

Country Status (3)

Country Link
EP (1) EP2976063A1 (el)
GR (1) GR1008168B (el)
WO (1) WO2014139677A1 (el)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026110A1 (en) * 1993-05-15 1994-11-24 Abbott Laboratories Stable quinolone and naphthyridine premix formulations
JPH0782141A (ja) * 1993-09-17 1995-03-28 Tanabe Seiyaku Co Ltd 動物用注射剤
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20090163484A1 (en) * 2006-03-08 2009-06-25 Bayer Animal Health Gmbh Pharmaceuticals containing fluoroquinolones
EP2078527A1 (en) * 2006-10-12 2009-07-15 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid preparation comprising gatifloxacin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906365A1 (de) 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE19937116A1 (de) 1999-08-06 2001-02-08 Bayer Ag Moxifloxacin Kochsalzformulierung
PT1225898E (pt) 1999-11-01 2003-10-31 Alcon Inc Composicoes farmaceuticas contendo um farmaco antibiotico de fluoroquinolona e goma xantana
US6872723B2 (en) * 2002-01-28 2005-03-29 Wyeth Stabilized difloxacin injectable solution
BRPI0714815A2 (pt) * 2006-08-07 2013-05-21 Bausch & Lomb composiÇço, e, uso de um (a) agonista e (b) um agente anti-infeccioso
CA2702761A1 (en) * 2007-11-01 2009-05-07 Bausch & Lomb Incorporated Non-aqueous water-miscible materials as vehicles for drug delivery
US20110319502A1 (en) * 2010-06-25 2011-12-29 Coffey Martin J Compositions and Methods for Enhancing Reduction of Spore-Forming Microorganisms

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026110A1 (en) * 1993-05-15 1994-11-24 Abbott Laboratories Stable quinolone and naphthyridine premix formulations
JPH0782141A (ja) * 1993-09-17 1995-03-28 Tanabe Seiyaku Co Ltd 動物用注射剤
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20090163484A1 (en) * 2006-03-08 2009-06-25 Bayer Animal Health Gmbh Pharmaceuticals containing fluoroquinolones
EP2078527A1 (en) * 2006-10-12 2009-07-15 Kyorin Pharmaceutical Co., Ltd. Aqueous liquid preparation comprising gatifloxacin

Also Published As

Publication number Publication date
WO2014139677A1 (en) 2014-09-18
EP2976063A1 (en) 2016-01-27

Similar Documents

Publication Publication Date Title
IL257481B (en) Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof
PH12015501957A1 (en) Pharmaceutical composition of s-ketamine hydrochloride
PH12015502013B1 (en) Pharmaceutical composition of s-ketamine hydrochloride
MX2015017964A (es) Inhibidores de bromodominio.
ZA201707096B (en) Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient
HK1216083A1 (zh) 经动脉的药物递送
EP3031464A4 (en) Preventive or therapeutic agent for ruminant animal mastitis
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
IL241175B (en) A pharmaceutical preparation for the treatment of fungal infections
PL3103453T3 (pl) Kompozycja lecznicza zawierająca jako składnik czynny heterocykliczny związek diaminokarboksyamidowy
EP3085369A4 (en) Therapeutic and/or preventive agent comprising 1-indansulfamide derivative for pain
GR1008186B (el) Φαρμακευτικο σκευασμα περιεχον ενα ατυπο αντιψυχωσικο παραγοντα και μεθοδος για την παρασκευη αυτου
GR1008168B (el) Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
BR112016029761A8 (pt) composições compreendendo um derivado de ácido quinolona carboxílico e agentes efervescentes, uso das mesmas e forma cristalina do referido derivado
GR1008169B (el) Φαρμακευτικο σκευασμα περιεχον εναν αντιβακτηριακο παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
GR1008258B (el) Οφθαλμικο σκευασμα ενος αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
TR201413590A3 (en) Pharmaceutical composition for use in treatment of vaginal infection comprises active substance or its derivative exhibiting antiprotozoal activity, and local anesthetic agent
ZA201304316B (en) Ophthalmic formulation of fluoroquinolone antibacterial agent and method for preparation thereof
UA91125U (uk) Антибактеріальна композиція
UA88315U (en) Antibacterial composition
IN2013MU01983A (el)
ZA201302189B (en) Pharmaceutical composition comprising a fluoroquinolone antibacterial agent and method for the preparation thereof

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140515